27 Sep 2018 07:00
Omega Diagnostics Group PLC
("Omega" or the "Company")
Allergy CE-Mark and first Purchase Order
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked five additional allergens, extending the menu to 58 allergens which can be run on the fully automated IDS Instrument.
These allergens will be supplied to IDS under the global distribution agreement announced on 20 April 2018. Ongoing investment to increase the menu is supported by the research and development grant of up to £1.8 million, which the Company secured from Scottish Enterprise in August 2016.
The Company also confirms that commercialisation activities with IDS are proceeding to plan and that it has received its first purchase order which it will supply by the end of October. The size of the order is in line with the Company's expectation, whereby sales are expected to be modest during the initial launch phase.
Contacts:
| Omega Diagnostics Group PLC | Tel: 01259 763 030 |
| Colin King, Chief Executive | www.omegadiagnostics.com |
| Kieron Harbinson, Group Finance Director |
|
|
|
|
| finnCap Ltd | Tel: 020 7220 0500 |
| Geoff Nash/James Thompson (Corporate Finance) |
|
| Camille Gochez (Corporate Broking) |
|
|
|
|
| Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
| Paul McManus | Mob: 07980 541 893 |
| Lianne Cawthorne | Mob: 07584 391 303 |
ODX.L (ODX)